Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 2
1949 3
1950 2
1951 5
1952 1
1953 2
1954 3
1955 3
1956 1
1958 3
1962 1
1963 1
1964 7
1965 3
1966 3
1967 1
1968 3
1969 1
1970 2
1973 1
1974 2
1975 2
1976 1
1988 1
1989 1
1990 1
1991 1
2000 1
2002 1
2004 1
2005 2
2006 2
2007 1
2008 1
2009 3
2010 8
2011 5
2012 3
2013 7
2014 7
2015 4
2016 3
2017 2
2018 5
2019 6
2020 15
2021 7
2022 7
2023 6
2024 8
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
Remdesivir for the Treatment of Covid-19 - Final Report.
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Beigel JH, et al. N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8. N Engl J Med. 2020. PMID: 32445440 Free PMC article. Clinical Trial.
Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data.
Torgersen J, Mezochow AK, Newcomb CW, Carbonari DM, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Lo Re V 3rd. Torgersen J, et al. JAMA Intern Med. 2024 Aug 1;184(8):943-952. doi: 10.1001/jamainternmed.2024.1836. JAMA Intern Med. 2024. PMID: 38913369 Free PMC article.
State-of-the-Art Review: Hepatitis C.
Lo Re V 3rd, Bhattacharya D, Price JC, Aronsohn A, Kim HN, Falade-Nwulia O, Zimmerman M, Trooskin S, Torgersen J. Lo Re V 3rd, et al. Among authors: torgersen j. Clin Infect Dis. 2025 Sep 16;81(2):e15-e26. doi: 10.1093/cid/ciaf334. Clin Infect Dis. 2025. PMID: 40971900 Review.
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Clifford Lane H, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. J Infect Dis. 2024 Sep 23;230(3):624-634. doi: 10.1093/infdis/jiae198. J Infect Dis. 2024. PMID: 38657001 Free PMC article. Clinical Trial.
Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virus.
Chalouni M, Van Santen DK, Berenguer J, Jarrin I, Miro JM, Klein MB, Young J, Torgersen J, Rentsch CT, Gill MJ, Epstein RL, Linas B, Zangerle R, Surial B, Rauch A, Touloumi G, Papadopoulos A, Wittkop L, Van Der Valk M, Boyd A, Monforte AD, Puoti M, Logan RW, Rein SM, Hernán MA, Lodi S. Chalouni M, et al. Among authors: torgersen j. AIDS. 2025 Jul 1;39(8):1074-1079. doi: 10.1097/QAD.0000000000004161. Epub 2025 Feb 18. AIDS. 2025. PMID: 39970192
Executive Summary: State-of-the-Art Review: Hepatitis C.
Lo Re V 3rd, Bhattacharya D, Price J, Aronsohn A, Kim HN, Falade-Nwulia S, Zimmerman M, Trooskin S, Torgersen J. Lo Re V 3rd, et al. Among authors: torgersen j. Clin Infect Dis. 2025 Sep 16;81(2):217-219. doi: 10.1093/cid/ciaf335. Clin Infect Dis. 2025. PMID: 40971898 No abstract available.
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status.
Lo Re V 3rd, Newcomb CW, Carbonari DM, Mezochow AK, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Torgersen J. Lo Re V 3rd, et al. Among authors: torgersen j. Pharmacoepidemiol Drug Saf. 2024 Dec;33(12):e70069. doi: 10.1002/pds.70069. Pharmacoepidemiol Drug Saf. 2024. PMID: 39662972 Free PMC article.
Clinical Microbiology in Xylazine-Associated Wound Infections.
Berg DM, Binkley A, Foster SD, Hinton M, Peiffer D, Huo SC, Torgersen J, Maguire C. Berg DM, et al. Among authors: torgersen j. Open Forum Infect Dis. 2025 Aug 7;12(8):ofaf384. doi: 10.1093/ofid/ofaf384. eCollection 2025 Aug. Open Forum Infect Dis. 2025. PMID: 40799792 Free PMC article.
[Medical families].
TORGERSEN J. TORGERSEN J. Tidsskr Nor Laegeforen. 1958 Jul 1;78(13-14):621-4. Tidsskr Nor Laegeforen. 1958. PMID: 13569457 Norwegian. No abstract available.
166 results